Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy

NCT01537055 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Eradication Rate for Helicobacter

Interventions

DRUG: levofloxacin-based sequential therapy
DRUG: levofloxacin-based triple therapy for 10 days

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]